Respiratory

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of pulmonary…

The following abstract highlights spotlight selected abstracts presented at the European Respiratory Society (ERS) Congress 2024. They…

The incidence of tuberculosis (TB) in England has decreased annually since 2011. However, the time from symptom onset to treatment…

Idiopathic pulmonary fibrosis (IPF) is inexorably progressive. Like IPF, other fibrotic lung diseases can exhibit this progression…

They cover key topics, including persistent airflow limitation in paediatric severe asthma, pulmonary rehabilitation, health-related…

The authors present a study that investigated the clinical features and therapy of superior sulcus1-3 non-small cell lung cancer during a 22-year period. There was a review of 100 patients who underwent curative surgery for superior sulcus non-small cell lung cancer during a 22-year period (July 1998 to December 2020). Patients with an apical tumour and Pancoast syndrome, superior sulcus tumours with invasion of the chest wall, vertebral body, and/or subclavian arteries met the inclusion criteria.

Advances in technology in recent years increased the long-term survival rate of patients with chronic respiratory failure. As a result, the number of patients receiving long-term home mechanical ventilation (LTHV) support is increasing worldwide.1 The most important step in the management of patients with home mechanical ventilation (HMV) is to ensure adequate oxygenation and ventilation. Successful care at home requires the presence of trained caregivers and accessibility to medical devices and a care team.